Oritavancin (LY333328)
Catalog No. A15771
Oritavancin (LY333328)是一种新型的半合成糖肽抗生素。2014年8月6日,FDA批准奥利万星用于治疗皮肤感染。奥利万星在体外具有对各种耐药和易感革兰氏阳性细菌(包括金黄色葡萄球菌,MRSA,肠球菌和链球菌)的有效且快速的杀菌活性。
Catalog Num | A15771 |
---|---|
M. Wt | 1793.1 |
Formula | C86H97Cl3N10O26 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 171099-57-3 |
Synonyms | LY333328 |
SMILES | CC1C(C(CC(O1)OC2C3C(=O)NC(C4=CC(=CC(=C4C5=C(C=CC(=C5)C(C(=O)N3)NC(=O)C6C7=CC(=C(C(=C7)OC8=C(C=C(C=C8)C(C(C(=O)NC(C(=O)N6)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)OC9C(C(C(C(O9)CO)O)O)OC1CC(C(C(O1)C)O)(C)NCC1=CC=C(C=C1)C1=CC=C(C=C1)Cl)OC1=C(C=C2C=C1)Cl)O)O)O)C(=O)O) |
Oritavancin (LY333328)是一种新型的半合成糖肽抗生素。2014年8月6日,FDA批准奥利万星用于治疗皮肤感染。奥利万星在体外具有对各种耐药和易感革兰氏阳性细菌(包括金黄色葡萄球菌,MRSA,肠球菌和链球菌)的有效且快速的杀菌活性。
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 5.58 mL | 27.88 mL | 55.77 mL |
0.5 mM | 1.12 mL | 5.58 mL | 11.15 mL |
1 mM | 0.56 mL | 2.79 mL | 5.58 mL |
5 mM | 0.11 mL | 0.56 mL | 1.12 mL |
*The above data is based on the productmolecular weight 1793.1. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.